News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
661,359 Results
Type
Article (31485)
Company Profile (171)
Press Release (629699)
Multimedia
Podcasts (48)
Webinars (10)
Section
Business (209815)
Career Advice (701)
Deals (31412)
Drug Delivery (72)
Drug Development (72528)
Employer Resources (53)
FDA (15309)
Job Trends (12832)
News (311271)
Policy (28923)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (1979)
Accelerated approval (44)
ADA (39)
Adcomms (12)
Allergies (184)
Alliances (44183)
ALS (192)
Alzheimer's disease (1574)
Antibody-drug conjugate (ADC) (448)
Approvals (16110)
Artificial intelligence (600)
ASCO (267)
Autoimmune disease (335)
Automation (37)
Bankruptcy (320)
Belgium (3)
Best Places to Work (10167)
BIO (53)
Biologics (11)
BIOSECURE Act (6)
Biosimilars (178)
BioSpace Insights (77)
Biotechnology (106)
Bispecific (1)
Bladder cancer (206)
Brain cancer (65)
Breast cancer (763)
Cancer (5787)
Cardiovascular disease (437)
Career advice (613)
Career pathing (20)
CAR-T (283)
CDC (37)
CDMO (57)
Celiac Disease (4)
Cell therapy (745)
Cervical cancer (54)
Clinical research (65535)
Collaboration (1896)
Commercialization (10)
Company closure (2)
Compensation (1580)
Complete response letters (55)
COVID-19 (1874)
CRISPR (93)
C-suite (1200)
Cystic fibrosis (131)
Data (8428)
Decentralized trials (2)
Denatured (27)
Depression (165)
Dermatology (113)
Diabetes (599)
Diagnostics (6066)
Digital health (58)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (250)
Drug pricing (158)
Drug shortages (24)
Duchenne muscular dystrophy (246)
Earnings (84667)
Editorial (42)
Employer branding (6)
Employer resources (54)
Events (110741)
Executive appointments (1040)
FDA (19517)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (29)
Funding (1526)
Gene editing (182)
Generative AI (37)
Gene therapy (543)
GLP-1 (774)
Government (3574)
Grass and pollen (4)
Guidances (392)
Healthcare (16784)
Hematology (154)
HIV (83)
Huntington's disease (46)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (100)
Immunology and inflammation (174)
Immuno-oncology (93)
Indications (224)
Infectious disease (2173)
Inflammatory bowel disease (204)
Inflation Reduction Act (13)
Influenza (120)
Intellectual property (308)
Interviews (80)
IPO (14656)
IRA (41)
Job creations (3053)
Job search strategy (565)
JPM (19)
Kidney cancer (22)
Labor market (54)
Layoffs (250)
Leadership (11)
Legal (7132)
Licensing (21)
Liver cancer (87)
Longevity (32)
Lung cancer (848)
Lymphoma (443)
Machine learning (46)
Management (19)
Manufacturing (834)
Marketing (10)
MASH (176)
Medical affairs (3)
Medical device (14475)
Medtech (14733)
Mergers & acquisitions (18075)
Metabolic disorders (1337)
mRNA (140)
Multiple sclerosis (182)
NASH (12)
Neurodegenerative disease (369)
Neuropsychiatric disorders (79)
Neuroscience (3018)
NextGen: Class of 2026 (5480)
Non-profit (3299)
Now hiring (46)
Obesity (523)
Opinion (134)
Ovarian cancer (224)
Pain (273)
Pancreatic cancer (312)
Parkinson's disease (335)
Partnered (28)
Patents (606)
Patient recruitment (837)
Patient selection (2)
Peanut (60)
People (55229)
Peptides (4)
Pharmaceutical (40)
Pharmacy benefit managers (25)
Phase 1 (20320)
Phase 2 (28756)
Phase 3 (21241)
Pipeline (10562)
Policy (191)
Postmarket research (2387)
Preclinical (8179)
Press Release (46)
Prostate cancer (313)
Psychedelics (41)
Radiopharmaceuticals (319)
Rare diseases (959)
Real estate (4690)
Recruiting (21)
Regenerative medicine (3)
Regulatory (23713)
Reports (35)
Research institute (1953)
Resumes & cover letters (89)
Rett syndrome (47)
RNA editing (13)
RSV (69)
Schizophrenia (168)
Series A (252)
Series B (192)
Service/supplier (6)
Sickle cell disease (99)
Special edition (9)
Spinal muscular atrophy (147)
Sponsored (22)
Startups (3106)
Stomach cancer (14)
Supply chain (97)
Tariffs (38)
The Weekly (21)
Vaccines (764)
Venture capital (51)
Weight loss (320)
Women's health (135)
Worklife (4)
Date
Last 7 days (442)
Last 30 days (1881)
Last 365 days (25989)
2026 (18740)
2025 (26046)
2024 (30759)
2023 (35198)
2022 (45657)
2021 (49465)
2020 (47605)
2019 (39023)
2018 (29427)
2017 (27586)
2016 (27067)
2015 (33404)
2014 (28523)
2013 (24205)
2012 (26508)
2011 (26904)
2010 (26034)
Location
Africa (517)
Alabama (92)
Alaska (4)
Arizona (392)
Arkansas (16)
Asia (34096)
Australia (5170)
California (14133)
Canada (3831)
China (1387)
Colorado (633)
Connecticut (596)
Delaware (412)
Europe (64053)
Florida (2173)
Georgia (466)
Hawaii (3)
Idaho (56)
Illinois (1180)
India (75)
Indiana (568)
Iowa (20)
Japan (602)
Kansas (131)
Kentucky (43)
Louisiana (53)
Maine (33)
Maryland (1701)
Massachusetts (9736)
Michigan (390)
Minnesota (782)
Mississippi (7)
Missouri (137)
Montana (28)
Nebraska (26)
Nevada (147)
New Hampshire (80)
New Jersey (3685)
New Mexico (20)
New York (3612)
North Carolina (1770)
North Dakota (7)
Northern California (7111)
Ohio (397)
Oklahoma (20)
Oregon (35)
Pennsylvania (2698)
Puerto Rico (27)
Rhode Island (51)
South America (762)
South Carolina (89)
South Dakota (1)
Southern California (5806)
Tennessee (234)
Texas (2350)
United States (49218)
Utah (433)
Vermont (1)
Virginia (307)
Washington D.C. (68)
Washington State (1141)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
661,359 Results for "illuminoss medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
IlluminOss Medical Breaks New Ground in Humerus Fracture Repair
IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, is addressing an unmet need in the burgeoning senior population.
November 13, 2023
·
3 min read
Genetown
IlluminOss Subsidiary ABL Medical Developing Anti-Microbial Blue Light Fiber Technology!
In 2018, IlluminOss Medical began offering a system in the US that used blue light delivered via a long fiber-optic catheter to harden light-curing liquid within balloon-like orthopedic implants.
February 9, 2024
·
2 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing
August 31, 2026
·
3 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend
August 4, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Activates Volunteer Intake for Melanoma Scan Beta After Launching First Human-Submitted Dataset Initiative
September 4, 2026
·
3 min read
Genetown
Fall today, move tomorrow! Local news story highlights using IlluminOss to fix an older patient’s fracture to deliver fast rehabilitation instead of immobilization
IlluminOss Medical is announcing its patented, minimally-invasive technology for fracture repair in older patients was just featured on the Rhode Island Channel 10 News.
February 13, 2024
·
2 min read
Business
IlluminOss Medical Appoints Craig Decker as Chief Executive Officer
July 10, 2024
·
2 min read
Genetown
Curing with Light! IlluminOss Celebrates 10,000 Light-Cured Implants Used By Surgeons To Strengthen Fragile Bone And Heal Geriatric Fractures
IlluminOss Medical announces it has reached the important benchmark of having placed 10,000 of its patient conforming implants designed for the treatment of geriatric fractures.
January 24, 2024
·
2 min read
Press Releases
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
August 28, 2026
·
5 min read
Sponsored
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
As AI-enabled Software as Medical Devices become more prevalent, regulatory agencies are responding with new guidelines and AI-specific authorisation routes. This article looks at current trends, suggests clinical considerations for medical device developers and anticipates AI-enabled SaMDs’ future progress.
August 17, 2026
·
6 min read
·
JoAnne Bronikowski
1 of 66,136
Next
